Status:
UNKNOWN
Chronic Kidney Disease at Northeast Taiwan: Biomarker and Multidisciplinary Care
Lead Sponsor:
Chang Gung Memorial Hospital
Collaborating Sponsors:
Ministry of Science and Technology, Taiwan
Conditions:
Chronic Kidney Disease
Eligibility:
All Genders
20-80 years
Phase:
NA
Brief Summary
CKD is a global endemic disease with increased comorbidities and mortality. The prevalence and the incidence of the end-stage renal disease (ESRD) are extremely high in Taiwan. Early diagnosis of dise...
Detailed Description
CKD is a global endemic disease with increased comorbidities and mortality. The prevalence and the incidence of the end-stage renal disease (ESRD) are extremely high in Taiwan. Early diagnosis of dise...
Eligibility Criteria
Inclusion
- Subjects visiting outpatient clinics of nephrology of Chang Gung Memorial Hospital
Exclusion
- Patient receiving dialysis or transplantation
- Unwilling to participate
Key Trial Info
Start Date :
March 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
8000 Patients enrolled
Trial Details
Trial ID
NCT04300387
Start Date
March 1 2011
End Date
December 1 2024
Last Update
March 9 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chang Gung Memorial Hospital
Keelung, Taiwan, 204